These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3517646)

  • 1. Type II diabetes: insulin versus oral agents.
    Martin DB
    N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646
    [No Abstract]   [Full Text] [Related]  

  • 2. Type II diabetes: insulin versus oral agents.
    Chalmers TC
    N Engl J Med; 1986 Nov; 315(19):1233-4. PubMed ID: 3531868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral antidiabetic agents for the general practitioner].
    Siegmund T
    MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
    [No Abstract]   [Full Text] [Related]  

  • 4. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with switching from oral hypoglycaemic agents to insulin therapy.
    Spoelstra JA; Stol RP; de Bruyne MC; Erkens JA; Herings RM; Leufkens HG; Grobbee DE
    Neth J Med; 2002 Jul; 60(6):243-8. PubMed ID: 12365467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2.
    Pagkalos EM
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S100-1. PubMed ID: 21864738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
    Leutenegger M; Bertin E; Grulet H
    Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract]   [Full Text] [Related]  

  • 13. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Koenen C
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 19. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in metabolic control after interruption of oral hypoglycemic agents in type II diabetic patients with secondary failure during combined therapy].
    De Mattia G; Laurenti O; Tullo MG; Ventura C; Albi F
    Clin Ter; 1988 Oct; 127(2):119-22. PubMed ID: 2976347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.